机译:达沙替尼,高剂量伊马替尼和nilotinibimatinib-resistant长期的治疗髓系白血病:系统回顾和经济评价
Southampton Health Technology Assessments Centre (SHTAC), University of Southampton, Southampton;
nilotinib; Clinical Effectiveness; Cost EffectivenessImatinibSprycelEconomic EvaluationInterventionNational Institute for Health and Clinical Excellence;
机译:达沙替尼和nilotinib imatinib-resistant或不宽容的慢性骨髓性白血病:系统评价和经济评价
机译:无需IBL激酶突变即可抵抗IMATINIB,NILOTINIB,DASATINIB和干扰素的晚期阶段性慢性髓细胞白血病
机译:没有ABL激酶突变的Bosutinib,Imatinib,Nilotinib,Dasatinib和抗干扰素的慢性粒细胞白血病的同种异体移植
机译:análisisdecosto-efectividad de nilotinib,dasatinib e imatinib como terapia deprimeralíneainleucemiamieloidecrónicaenColombia,2012